Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin Continuous vs Intermittent Infusion in SICU
NCT01786161Phase 4Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2013
- Primary completion
- Jun 2016
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in Staphylococcus aureus infection, sponsored by Massachusetts General Hospital. Started Sep 2013; status: terminated.
02
Drugs
vancomycin
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT01786161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01786161.